Vermillion Inc. (VRML) is in the Health Care Industry

Vermillion is involved in the discovery, development and commercialization of specialty diagnostic tests that provide physicians with information, with which to manage their patients' care and that improve patient outcomes. Co. intends to do this using translational proteomics, which is the process of answering clinical questions by utilizing protein separation tools to identify and resolve variants of specific biomarkers, developing assays and commercializing tests. Specifically, the clinical questions addressed by Co. include early disease detection, treatment response, monitoring of disease progression, prognosis and others.